Provided by Tiger Trade Technology Pte. Ltd.

Lyell Immunopharma, Inc.

8.63
+0.07000.82%
Volume:67.10K
Turnover:564.66K
Market Cap:211.47M
PE:-0.73
High:8.63
Open:8.52
Low:8.21
Close:8.56
52wk High:45.00
52wk Low:8.21
Shares:24.50M
Float Shares:10.79M
Volume Ratio:0.77
T/O Rate:0.62%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-11.8281
EPS(LYR):-16.0562
ROE:-93.28%
ROA:-34.18%
PB:0.90
PE(LYR):-0.54

Loading ...

Feb 15, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 17, 2021

Major Issues Report

8-K - Current report
Dec 03, 2021

Major Issues Report

8-K - Current report
Nov 12, 2021

Major Issues Report

8-K - Current report
Nov 12, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 28, 2021

Major Issues Report

8-K - Current report
Oct 01, 2021

Major Issues Report

8-K/A [Amend] - Current report
Sep 30, 2021

Major Issues Report

8-K - Current report
Aug 12, 2021

Major Issues Report

8-K - Current report
Aug 12, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 21, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jun 14, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jun 14, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jun 09, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jun 07, 2021

Correspondence

CORRESP [Cover] - Correspondence